We are live on ! Find out more
UBX

Unity Biotechnology
UBX

Delisted

UBX was delisted on the 8th of July, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of UBX yet.

UBX Hedge Fund Activity: Q4 2025 in Review

0 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Unity Biotechnology (UBX) for Q4 2025, worth a combined $0 — down 100% from $1.68K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of UBX and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Osaic Holdings, exiting entirely with an estimated $831 sold.

  • 0 institutional investors held Unity Biotechnology (UBX) as of Q4 2025, down from 6 in Q3 2025.
  • Funds reported $0 of Unity Biotechnology stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Unity Biotechnology positions in Q4 2025 and 5 closed out, a net change of -5 holders.
  • The largest Unity Biotechnology seller in Q4 2025 was Osaic Holdings, an estimated $831 sold.

Based on aggregated 13F filings for Q4 2025.